Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections.
Sablone S, Cardinale AN, Gorini E, Diella L, Belati A, Bussini L, Cento V, Bartoletti M, Introna F, Bavaro DF. Sablone S, et al. Among authors: belati a. J Forensic Leg Med. 2024 Oct;107:102762. doi: 10.1016/j.jflm.2024.102762. Epub 2024 Sep 23. J Forensic Leg Med. 2024. PMID: 39326110 Free article.
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study.
Belati A, Diella L, Bavaro DF, De Santis L, Cotugno S, De Gennaro N, Brindicci G, Maggiore ME, Indraccolo F, Di Gennaro F, Ronga L, Mosca A, Stufano M, Dalfino L, Grasso S, Saracino A. Belati A, et al. Int J Antimicrob Agents. 2024 Aug;64(2):107247. doi: 10.1016/j.ijantimicag.2024.107247. Epub 2024 Jun 19. Int J Antimicrob Agents. 2024. PMID: 38906485
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study.
Simone S, Pronzo V, Pesce F, Bavaro DF, Infante B, Mercuri S, Schirinzi A, Panaro A, Conte E, Belati A, Troise D, Pontrelli P, Conserva F, Gallo P, Panico M, Spilotros M, Lucarelli G, Saracino A, Stallone G, Di Serio F, Ditonno P, Gesualdo L. Simone S, et al. Among authors: belati a. J Nephrol. 2024 Jul;37(6):1539-1550. doi: 10.1007/s40620-024-01889-9. Epub 2024 May 23. J Nephrol. 2024. PMID: 38780697 Free PMC article.
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study.
Di Gennaro F, Papagni R, Segala FV, Pellegrino C, Panico GG, Frallonardo L, Diella L, Belati A, Santoro CR, Brindicci G, Balena F, Bavaro DF, Montalbò D, Guido G, Calluso L, Di Tullio M, Sgambati M, Fiordelisi D, De Gennaro N, Saracino A. Di Gennaro F, et al. Among authors: belati a. BMC Infect Dis. 2024 Apr 22;24(1):423. doi: 10.1186/s12879-024-09315-y. BMC Infect Dis. 2024. PMID: 38649892 Free PMC article.
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey.
Di Gennaro F, Segala FV, Guido G, Poliseno M, De Santis L, Belati A, Santoro CR, Bottalico IF, Pellegrino C, Novara R, Frallonardo L, Cormio M, Camporeale M, Cotugno S, Giliberti V, Di Gregorio S, Totaro V, Catucci N, De Giosa A, Giusto R, Lanera IV, Angarano G, Lo Caputo S, Saracino A. Di Gennaro F, et al. Among authors: belati a. PLoS One. 2024 Apr 19;19(4):e0301297. doi: 10.1371/journal.pone.0301297. eCollection 2024. PLoS One. 2024. PMID: 38640112 Free PMC article.
Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study.
Bavaro DF, Diella L, Pizzutilo P, Catino A, Signorile F, Pesola F, Belati A, Marech I, Garrisi V, Lamorgese N, Di Gennaro F, Saracino A, Galetta D. Bavaro DF, et al. Among authors: belati a. Scand J Immunol. 2023 Sep;98(3):e13303. doi: 10.1111/sji.13303. Epub 2023 Jun 20. Scand J Immunol. 2023. PMID: 38441223 Free article.
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
Rando E, Salvati F, Sangiorgi F, Catania F, Leone E, Oliva A, Di Gennaro F, Fiori B, Cancelli F, Figliomeni S, Bobbio F, Sacco F, Bavaro DF, Diella L, Belati A, Saracino A, Mastroianni CM, Fantoni M, Murri R. Rando E, et al. Among authors: belati a. J Antimicrob Chemother. 2024 Feb 1;79(2):453-461. doi: 10.1093/jac/dkad404. J Antimicrob Chemother. 2024. PMID: 38169441 Free PMC article.
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.
Bavaro DF, Belati A, Bussini L, Cento V, Diella L, Gatti M, Saracino A, Pea F, Viale P, Bartoletti M. Bavaro DF, et al. Among authors: belati a. Expert Opin Drug Saf. 2024 Jan;23(1):9-36. doi: 10.1080/14740338.2023.2299377. Epub 2023 Dec 29. Expert Opin Drug Saf. 2024. PMID: 38145925 Review.
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study.
Bavaro DF, Papagni R, Belati A, Diella L, De Luca A, Brindicci G, De Gennaro N, Di Gennaro F, Romanelli F, Stolfa S, Ronga L, Mosca A, Pomarico F, Dell'Aera M, Stufano M, Dalfino L, Grasso S, Saracino A. Bavaro DF, et al. Among authors: belati a. Infect Dis Ther. 2023 Aug;12(8):2147-2163. doi: 10.1007/s40121-023-00854-6. Epub 2023 Sep 1. Infect Dis Ther. 2023. PMID: 37653122 Free PMC article.
32 results